Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomized, Double-Blind, Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 with Background Treatment in Subjects with Lupus Nephritis

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/20/19 → 08/19/22

Funding

  • Bristol Myers Squibb Company: $40,722.00